CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
2 research outputs found
Feasibilty study of gemcitabine and cisplatin administered every two weeks in patients with advanced urothelial tumors and impaired renal function
Author
A Yagoda
Albert Font
+26Â more
Carlos MesĂa
CJ Logothetis
Cristina Suárez
DD Hoff Von
DS Kaufman
G Carteni
G LĂłpez-Vivanco
GM Mead
H Maase Von der
Ignasi Tusquets
J Bellmunt
J Bellmunt
Joan Albanell
Joan Carles
M Nogué-Aligué
M. Gallén
Marta Suárez
Miquel Nogué
Montserrat Doménech
National Cancer Institute
P Therase
PJ Loehrer
R Colomer
R Petrioli
WF Whitmore
Xavier Fabregat
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
Cisplatin plus oral vinorelbine as first-line treatment for advanced non-small-cell lung cancer: a prospective study confirming that the day-8 hemogram is unnecessary
Author
A Jemal
A. Artal
+31Â more
A. Sánchez
A. Sánchez
C Puozzo
DF Cella
DG Pfister
EH Tan
F. J. PĂ©rez
FR Hirsch
G Liu
GV Scagliotti
J. de Castro
J. M. Sánchez Torres
JH Schiller
K Kelly
K Kelly
KL Goa
L Jensen
M Marty
M Provencio
M. DĂłmine
M. Provencio
MM Borner
MS Aapro
N. Viñolas
P Therase
P Variol
PA Bunn Jr
R Bugat
V Gebbia
V Gebbia
V Gebbia
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref